Augmentation of cortical bone mineral density in women with polycystic ovary syndrome: A peripheral quantitative computed tomography (pQCT) study

Human Reproduction

Volumn 25, Issue 8, 2010, Pages 2107-2114

  Kassanos, D ^a   Trakakis, E ^a   Baltas, C S ^b   Papakonstantinou, O ^a   Simeonidis, G ^a   Salamalekis, G ^a   Grammatikakis, I ^a   Basios, G ^a   Labos, G ^a   Skarantavos, G ^c   Balanika, A ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b G GENNIMATAS GENERAL HOSPITAL   (Greece)

^c NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

bone mineralization; cortical density; endocrinology; polycystic ovaries; pQCT

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BONE DENSITY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; FEMALE; HUMAN; OBESITY; OVARY POLYCYSTIC DISEASE; PARAMETER; PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY; TIBIA; TRABECULAR BONE;

EID: 77954973603     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deq149     Document Type: Article

References (47)

1. Adami S, Zamberlan N, Castello R, Tosi F, Gatti D, Moghetti P. Effect of hyperandrogenism and menstrual cycle abnormalities on bone mass and bone turnover in young women. Clin Endocrinol (Oxf) 1998;48:169-173.
2. Anasti JN, Kalantaridou SN, Kimzey LM, Defensor RA, Nelson LM. Bone loss in young women with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol 1998;91:12-15.
3. Angelopoulous NG, Katonda E, Rombopoulos G, Goula A, Kaltzidou V, Klatsas D, Ioannia P, Tolis G. Evaluation of bone mineral density of the lumbar spine in patients with beta-thalassemia major with dual-energy X-ray absorptiometry and quantitative computed tomography: a comparison study. J Pediatr Hematol Oncol 2006;28:73-78.
4. Augat P, Reeb H, Claes LE. Prediction of fracture load at different skeletal sites by geometric properties of the cortical shell. J Bone Miner Res 1996; 11:1356-1363.
5. Bailey DA, McKay HA, Mirwald RL, Crocker PR, Faulkner RA. A six-year longitudinal study of the relationship of physical activity to bone mineral accrual in growing children: the University of Saskatchewan. Bone Mineral Accrual Study. J Bone Miner Res 1999;14:1672-1679.
6. Baltas CS, Balanika AP, Raptou PD, Tournis S, Lyritis GP. Clinical practice guidelines proposed by the Hellenic Foundation of Osteoporosis for the management of osteoporosis based on DXA results. J Musculoskelet Neuronal Interact 2005;5:388-392.
7. Botsis D, Kassanos D, Pyrgiotis E, Zourlas PA. Sonographic incidence of polycystic ovaries in a gynecological population. Ultrasound Obstet Gynecol 1995;6:182-185.
8. Carmina E, Guastella E, Longo RA, Rini GB, Lobo RA. Correlates of increased lean muscle mass in women with polycystic ovary syndrome. Eur J Endocrinol 2009;161:583-589.
9. Cresswell D, Fraser J, Bruce R, Egger C, Phillips P, Barker DJ. Relationship between polycystic ovaries, body mass index and insulin resistance. Acta Obstet Gynecol Scand 2003;82:61-64.
10. Currey JD. The effect of porosity and mineral content on the Young's modulus of elasticity of compact bone. J Biomech 1988;21:131-140.
11. Dagogo-Jack S, Ali N, Qurttom M. Augmentation of bone mineral density in hirsute women. J Clin Endocrinol Metab 1997;82:2821-2825.
12. Diamanti-Kandarakis E, Kouli C, Bergiele AT, Filandra F, Tsianateli T, Spina G, Zapanti E, Bartzis M. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999;84:4006-4011.
13. DiCarlo C, Shoham Z, MacDougall J, Patel A, Hall ML, Jacobs HS. Polycystic ovaries as a relative protective factor for bone mineral density loss in young women with amenorrhea. Fertil Steril 1992; 57:314-319.
14. Dixon JE, Rodin A, Murby B, Chapman MG, Fogelman I. Bone mass in hirsute women with androgen excess. Clin Endocrinol (Oxf) 1989; 30:271-277.
15. Douchi T, Oki T, Yamasaki H, Kuwahata R, Nakae M, Nagata Y. Relationship of androgens to muscle size and bone mineral density in women with polycystic ovary syndrome. Obstet Gynecol 2001; 98:445-449.
16. Ferreti JL. Perspectives of pQCT technology associated to biomechanical studies in skeletal research employing rat models. Bone 1995; 17:353-364.
17. Gallewaert F, Boonen S, Vanderschueren D. Sex steroids and the male skeleton: a tale of two hormones. Trend Endocrinol Metab 2009; Oct 16 [Epub a head of Print].
18. Glintborg D, Andersen M, Hagen C, Heickendorff L, Hermann A. Association of pioglitazone treatment with decreased bone mineral density in obese premenopausal patients with polycystic ovary syndrome: a randomized, placebo-controlled trial. J Clin Endocrinol Metab 2008;93:1696-1701.
19. Good C, Tulchinsky M, Mauger D, Demers LM, Legro RS. Bone mineral density and body composition in lean women with polycystic ovary syndrome. Fertil Steril 1999;72:21-25.
20. Gulekli B, Turhan NO, Senoz S, Kukner S, Oral H, Gokmen O. Endocrinological, ultrasonographic and clinical findings in adolescent and adult polycystic ovary patients; a comparative study. Gynecol Endocrinol 1993;7:273-277.
21. Kanis JA. Assessment of fracture risk and its application to screening for post-menopausal osteoporosis: synopsis of a WHO report. Osteoporos Int 1994;4:368-381.
22. Kaufman JM, T'Sjoen G. Estrogen-specific action on bone geometry and volumetric bone density: longitudinal observations in an adult with complete androgen insensitivity. Bone 2009;45:392-397.
23. Kearbey J, Gao W, Fisher S, Wu D, Miller D, Dalton J. Effects of selective androgen receptor modulator (SARM) treatment in osteopenic female rats. Pharm Res 2009; Sep 1. [Epub ahead of print].
24. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998;83:3078-3082.
25. Kyung TW, Lee JE, Phan TV, Yu R, Choi HS. Osteoclastogenesis by bone marrow-derived macrophages is enhanced in obese mice. J Nut 2009; 139:502-506.
26. Lapauw B, Taes Y, Goemaere S, Toye K, Zmierczak HG, Kaufman JM. Anthropometric and skeletal phenotype in men with idiopathic osteoporosis and their sons is consistent with deficient estrogen action during maturation. J Clin Endocrinol Metab 2009;94:4300-4308.
27. McCleary LBS. Bone mineral density in women with polycystic ovary syndrome. 2007; Submitted to the Graduate Faculty of The Graduate School of Public Health in partial fulfilment of the requirements for the degree of Master of Science. University of Pittsburgh.
28. Norman R, Dewailly D, Legro R, Hickey T. Polycystic ovary syndrome. Lancet 2007;370:685-697.
29. Noyan V, Yucel A, Sagsoz N. The association of bone mineral density with insulin resistance in patients with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol 2004;115:200-205.
30. Polson DW, Adams J, Wadsworth J. Polycystic ovaries: a common finding in normal women. Lancet 1998;1:870-872.
31. Rho JY, Ashman RB, Turnrer CH. Young's modulus of trabecular and cortical bone material. Ultrasonic and microtensil measurements. J Biomech 1993;26:110-119.
32. Roddam AW, Appleby P, Neale R, Dowsett M, Folkerd E, Tipper S, Allen NE, Key TJ. Association between endogenous plasma hormone concentrations and fracture risk in men and women: the EPIC-Oxford prospective cohort study. J Bone Miner Metab 2009;27:485-493.
33. Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnosis criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004; 19:41-47.
34. Russo CR, Lauretani F, Bandinelli S, Bartali B, Iorio ADi, Volpato S, Guralnik JM, Russo CR, Taccetti G, Cavena P et al. Volumetric bone density and geometry assessed by peripheral quantitative computed tomography in uremic patients on maintenance hemodialysis. Osteoporos Int 1998;8:443-448.
35. Russo CR, Lauretani F, Bandinelli S, Bartali B, Di Iorio A, Volpato S, Guralnik JM, Harris T, Ferrucci L. Aging bone in men and women: beyond changes in bone mineral density. Osteoporos Int 2003; 14:531-538.
36. Sum M, Warren MP. Hypothalamic amenorrhea in young women with underlying polycystic ovary syndrome. Fertil Steril 2009;92:2106-2108.
37. Taes Y, Lapauw B, Vandewalle S, Zmierczak H, Goemaere S, Vanderschueren D, Tivesten A, Movérare-Skrtic S, Chagin A, Venken K et al. Additive protective effects of estrogen and androgen treatment on trabecular bone in ovariectomized rats. J Bone Miner Res 2004;19:1833-1839.
38. Tamura N, Kurabayashi T, Nagata H, Matsushita H, Yahata T, Tanaka K Effects of testosterone on cancellous bone, marrow adipocytes, and ovarian phenotype in a young female rat model of polycystic ovary syndrome. Fertil Steril 2005;84:1277-1284.
39. To M, Wong MA. Comparison of bone mineral density in oligomenorrhoeic adolescents with polycystic ovaries and normal ovaries. Gynecol Endocrinol 2005;20:237-242.
40. Trakakis E, Balanika A, Baltas C, Loghis C, Simeonidis G, Vaggopoulos V, Papakonstantinou O, Gouliamos A, Salamalekis G, Kassanos D. Hemodynamic alterations and wall properties in large arteries of young, normotensive, and non-obese women with polycystic ovary syndrome. J Endocrinol Invest 2008;31:1001-1007.
41. Turner CH, Burr DB. Basic biomechanical measurements of bone. A tutorial. Bone 1993;14:595-608.
42. Vanderschueren D, Vandenput L, Boonen S, Lindberg M, Bouillon R, Ohlsson C. Androgens and bone. Endocr Rev 2004;25:389-425.
43. Vanderschueren D, Venken K, Ophoff J, Bouillon R, Boonen S. Sex steroids and the periosteum-reconsidering the roles of androgens and estrogens in periosteal expansion. J Clin Endocrinol Metab 2006; 91:378-382.
44. Warren MP, Brooks-Gunn J, Fox RP, Holderness CC, Hyle EP, Hamilton WG. Osteopenia in exercise-associated amenorrhea using ballet dancers as a model: a longitudinal study. J Clin Endocrinol Metab 2002;87:3162-3168.
45. Wilhelm G, Felsenberg D, Bogusch G, Willnecker J, Thaten J, Gummert P. Biomechanical examinations for validation of the bone strength strain index (SSI), calculated by peripheral quantitative computed tomography. In: Lyritis G (ed). Musculoskeletal Interactions. Basic and Clinical Aspects. Vol.2, Athens: Hylonome Edition, 1999, 105-110.
46. Yuksel O, Dokmetas HS, Topcu S, Erselcan T, Sencan M. Relationship between bone mineral density and insulin resistance in polycystic ovary syndrome. J Bone Miner Metab 2001;19:257-262.
47. Zborowski J, Cauley J, Talbott E, Guzick D, Winters J. Bone mineral density, androgens, and the polycystic ovary: the complex and controversial issue of androgenic influence on female bone. J Clin Endocrinol Metab 2000;85:3496-3506.